Chargement en cours...
Effect of intrathecal dexmedetomidine versus intravenous dexmedetomidine on subarachnoid anesthesia with hyperbaric bupivacaine
BACKGROUND AND AIM: Alpha-2 agonists such as dexmedetomidine when given intravenously or intrathecally as an adjuvant potentiate subarachnoid anesthesia. We studied the difference in subarachnoid anesthesia when supplemented with either intrathecal or intravenous dexmedetomidine. MATERIAL AND METHOD...
Enregistré dans:
| Publié dans: | J Anaesthesiol Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer - Medknow
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7812950/ https://ncbi.nlm.nih.gov/pubmed/33487907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/joacp.JOACP_323_17 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|